Using lab drug tests to help pick treatment for hard-to-treat brain tumors
Original title: Pharmacoscopy for Patients With Refractory Primary Brain Tumors
How far along is this research?
This is a trial that is enrolling or has been updated. It is not a finding yet.
This is a mid-stage study that is still testing if the method works in people.
Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.
The trial team last updated this record on . Always check the trial page for the latest.
The short version
This study tests whether lab tests of drugs can help choose a treatment for each person.
Who this trial is for. This trial is for people with a primary brain tumor, such as glioblastoma: A glioma that is given grade 4, the highest grade. It grows fast. Treatment usually starts soon after it is found. It often means surgery, then radiation and chemotherapy. See the glossary, that has not responded to treatment. It tests a lab method called pharmacoscopy, which tries drugs outside the body to help pick a treatment for each person.
Where it stands. The team wants to learn if this way of choosing treatment can work in real patient care. The trial has not reported results yet.
What this means, and what it doesn't
What it could mean: This is one step toward treatment chosen for each person's own tumor. If you have a brain tumor that has stopped responding to treatment, you could ask your care team if this trial might fit you.
What it doesn't mean: This trial is a test, not a proven treatment. The method has been tried in the lab, but not yet shown to help patients. Joining a trial does not promise that it will help you. It is not a cure.
Source: ClinicalTrials.gov, September 21, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.